Effect of high-fiber and high-oil diets on the fecal flora of swine.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 203923)

Published in Appl Environ Microbiol on July 01, 1987

Authors

W E Moore1, L V Moore, E P Cato, T D Wilkins, E T Kornegay

Author Affiliations

1: Department of Anaerobic Microbiology, Virginia Polytechnic Institute, Blacksburg.

Articles cited by this

Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol (1974) 20.50

Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol (1976) 7.52

Polyacrylamide slab gel electrophoresis of soluble proteins for studies of bacterial floras. Appl Environ Microbiol (1980) 5.54

Bacteriology of experimental gingivitis in young adult humans. Infect Immun (1982) 4.14

Comparative bacteriology of juvenile periodontitis. Infect Immun (1985) 3.09

Isolation and identification of fecal bacteria from adult swine. Appl Environ Microbiol (1977) 2.04

[Comparative studies on lactobacilli from the faeces of man, swine and chickens]. Zentralbl Bakteriol Orig (1969) 1.87

Types and distribution of anaerobic bacteria in the large intestine of pigs. Appl Environ Microbiol (1979) 1.69

Characterization of predominant bacteria from the colons of normal and dysenteric pigs. Appl Environ Microbiol (1984) 1.45

Comparison of three techniques for the total count of anaerobes from intestinal contents of pigs. Appl Microbiol (1972) 1.16

Influence of dietary fiber on xylanolytic and cellulolytic bacteria of adult pigs. Appl Environ Microbiol (1987) 1.10

[The Bacteriodaceae flora in the faeces of pigs (author's transl)[]. Zentralbl Bakteriol Orig A (1976) 1.06

Influence of high-fiber diet on bacterial populations in gastrointestinal tracts of obese- and lean-genotype pigs. Appl Environ Microbiol (1982) 1.03

Isolation from swine feces of a bacterium which decarboxylates p-hydroxyphenylacetic acid to 4-methylphenol (p-cresol). Appl Environ Microbiol (1987) 0.95

The precursors of fecapentaenes. A preliminary report. Ann Ist Super Sanita (1986) 0.82

Microbial biosynthesis of fecapentaenes. Prog Clin Biol Res (1986) 0.81

Articles by these authors

THE PROPHYLACTIC USE OF SULFANILAMIDE IN STREPTOCOCCAL RESPIRATORY INFECTIONS, WITH ESPECIAL REFERENCE TO RHEUMATIC FEVER. J Clin Invest (1939) 11.04

Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1976) 9.38

Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria. Antimicrob Agents Chemother (1973) 9.35

Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol (1977) 8.29

Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26

Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88

Anaerobic bacteria of the gastrointestinal flora and their occurrence in clinical infections. J Infect Dis (1969) 6.07

The bacteria of periodontal diseases. Periodontol 2000 (1994) 5.72

Polyacrylamide slab gel electrophoresis of soluble proteins for studies of bacterial floras. Appl Environ Microbiol (1980) 5.54

Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44

Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1979) 5.10

Biological activities of toxins A and B of Clostridium difficile. Infect Immun (1982) 4.62

Development of a micromethod for identification of anaerobic bacteria. Appl Microbiol (1975) 4.58

Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol (1977) 4.09

Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06

Production of Clostridium difficile antitoxin. Infect Immun (1980) 3.95

Micromethod for identification of anaerobic bacteria: design and operation of apparatus. Appl Microbiol (1975) 3.80

Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40

Comparative bacteriology of juvenile periodontitis. Infect Immun (1985) 3.09

Bacteriology of moderate (chronic) periodontitis in mature adult humans. Infect Immun (1983) 3.03

Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res (1990) 2.93

Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89

Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J Clin Microbiol (1982) 2.86

Arginine, a growth-limiting factor for Eubacterium lentum. J Bacteriol (1976) 2.67

Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65

Production by Salmonella typhimurium of 2,3-dihydroxybenzoylserine, and its stimulation of growth in human serum. J Infect Dis (1970) 2.62

Some current concepts in intestinal bacteriology. Am J Clin Nutr (1978) 2.54

Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.49

Medium-dependent inhibition of Peptostreptococcus anaerobius by sodium polyanetholsulfonate in blood culture media. J Clin Microbiol (1976) 2.46

Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol (1985) 2.46

Actinomyces georgiae sp. nov., Actinomyces gerencseriae sp. nov., designation of two genospecies of Actinomyces naeslundii, and inclusion of A. naeslundii serotypes II and III and Actinomyces viscosus serotype II in A. naeslundii genospecies 2. Int J Syst Bacteriol (1990) 2.26

Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies. Infect Immun (1982) 2.14

The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect Immun (1995) 2.06

Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun (1986) 2.01

Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun (1988) 2.00

Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect Immun (1989) 2.00

Purification and characterization of an enterotoxin from Bacteroides fragilis. Infect Immun (1992) 1.97

Commercial latex test for Clostridium difficile toxin A does not detect toxin A. J Clin Microbiol (1986) 1.92

Differential effects of Clostridium difficile toxins on tissue-cultured cells. J Clin Microbiol (1982) 1.87

Resistance of some species of Clostridium to clindamycin. Antimicrob Agents Chemother (1973) 1.81

Intrageneric coaggregation among strains of human oral bacteria: potential role in primary colonization of the tooth surface. Appl Environ Microbiol (1990) 1.79

Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics. Antimicrob Agents Chemother (1978) 1.78

In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis. Antimicrob Agents Chemother (1975) 1.78

Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin. J Clin Microbiol (1982) 1.75

Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice. Antimicrob Agents Chemother (1974) 1.71

Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol (1991) 1.67

Coaggregation properties of human oral Veillonella spp.: relationship to colonization site and oral ecology. Appl Environ Microbiol (1988) 1.67

Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A. Infect Immun (1991) 1.66

Fibrinolytic activity of oral anaerobic bacteria. Arch Oral Biol (1978) 1.65

Toxin A of Clostridium difficile is a potent cytotoxin. J Clin Microbiol (1990) 1.65

Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice. Infect Immun (1976) 1.64

Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology (1996) 1.63

Inhibition of Bacteroides fragilis on blood agar plates and reversal of inhibition by added hemin. J Clin Microbiol (1976) 1.63

Beta-Lactamase activity in strains of Bacteroides melaninogenicus and Bacteroides oralis. Antimicrob Agents Chemother (1977) 1.62

Laminarinase (beta-glucanase) activity in Bacteroides from the human colon. Appl Environ Microbiol (1977) 1.61

Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo. Infect Immun (1995) 1.59

Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun (1987) 1.57

Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity. Infect Immun (1986) 1.57

Identification of Clostridium botulinum, Clostridium argentinense, and related organisms by cellular fatty acid analysis. J Clin Microbiol (1991) 1.56

Requirement of heme for growth of Bacteroides fragilis. Appl Environ Microbiol (1977) 1.53

Clostridium difficile toxin A in infants. J Infect Dis (1983) 1.53

EXPERIMENTAL INDUCTION OF ERYTHEMA NODOSUM. J Clin Invest (1936) 1.51

Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences. Arch Biochem Biophys (1987) 1.51

Bacteriology of experimental gingivitis in children. Infect Immun (1984) 1.50

Vaspar broth-disk procedure for antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1980) 1.50

Molecular basis for the pathological actions of Clostridium perfringens iota toxin. Infect Immun (1987) 1.47

Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile. J Med Microbiol (1992) 1.47

The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect Immun (1997) 1.46

Cytochrome spectrum of an obligate anaerobe, Eubacterium lentum. J Bacteriol (1976) 1.45

Bacteriophages of Bacteroides. Rev Infect Dis (1980) 1.44

Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect Immun (1991) 1.44

Investigation of the influences of puberty, genetics, and environment on the composition of subgingival periodontal floras. Infect Immun (1993) 1.44

Clostridium perfringens iota toxin: synergism between two proteins. Toxicon (1986) 1.43

Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun (1991) 1.42

Cholesterol-reducing bacterium from human feces. Appl Environ Microbiol (1977) 1.40

Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). Infect Immun (1988) 1.40

Influence of pencillinase production by strains of Bacteroides melaninogenicus and Bacteriodes oralis on pencillin therapy of an experimental mixed anaerobic infection in mice. Arch Oral Biol (1976) 1.39

Bacteriology of human gingivitis. J Dent Res (1987) 1.38

Cloning and characterization of the gene for the metalloprotease enterotoxin of Bacteroides fragilis. FEMS Microbiol Lett (1997) 1.36

Characterization of cross-reactive proteins detected by Culturette Brand Rapid Latex Test for Clostridium difficile. J Clin Microbiol (1988) 1.34

Comparison of culture, cytotoxicity assays, and enzyme-linked immunosorbent assay for toxin A and toxin B in the diagnosis of Clostridium difficile-related enteric disease. Diagn Microbiol Infect Dis (1986) 1.34

Use of the RapID-ANA System to screen for enzyme activities that differ among species of bile-inhibited Bacteroides. J Clin Microbiol (1986) 1.33

Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun (1992) 1.32

Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine. Infect Immun (1987) 1.31

Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother (1987) 1.29

Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing. Antimicrob Agents Chemother (1978) 1.26

Lactobacillus uli sp. nov. and Lactobacillus rimae sp. nov. from the human gingival crevice and emended descriptions of lactobacillus minutus and Streptococcus parvulus. Int J Syst Bacteriol (1991) 1.26

Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J Clin Invest (1996) 1.26

Electrophoretic study of Clostridium species. J Clin Microbiol (1982) 1.24

Isolation of auxotrophs of Bacteroides fragilis. Can J Microbiol (1978) 1.21

High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proc Natl Acad Sci U S A (1992) 1.20

Positive regulation of Clostridium difficile toxins. Infect Immun (1997) 1.17

Taxonomy of anaerobes: present state of the art. Rev Infect Dis (1984) 1.17

Bacteriocin production by strains of Bacteroides isolated from human feces and the role of these strains in the bacterial ecology of the colon. Antimicrob Agents Chemother (1977) 1.16

Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity. Microb Pathog (1994) 1.14

TechLab and alexon Giardia enzyme-linked immunosorbent assay kits detect cyst wall protein 1. J Clin Microbiol (1999) 1.13

Carbadox in the prevention of experimentally induced swine dysentery. J Am Vet Med Assoc (1968) 1.12

Variation in periodontal floras. Infect Immun (1984) 1.12

The fecapentaenes, potent mutagens from human feces. Chem Res Toxicol (1992) 1.11